Vascular endothelial dysfunction and nutritional compounds in early type 1 diabetes
1Nationwide Children's Hospital ED422, 700 Children's Drive Columbus, OH 43205, USA. Robert.Hoffman@nationwidechildrens.org.
Current Diabetes Reviews
|June 14, 2014
Summary
Cardiovascular disease is a major risk for type 1 diabetes patients. Antioxidants like ascorbic acid may improve vascular endothelial function, potentially reducing this risk.
Area of Science:
- Endocrinology
- Cardiology
- Metabolic Disorders
Background:
- Cardiovascular disease (CVD) is the leading cause of mortality in type 1 diabetes (T1D).
- Vascular endothelial dysfunction, a precursor to CVD, is often observed early in T1D, even in adolescents.
- Hyperglycemia, particularly oscillating patterns, contributes to endothelial dysfunction via oxidative stress.
Purpose of the Study:
- To review the role of antioxidants in mitigating vascular endothelial dysfunction in type 1 diabetes.
- To explore potential therapeutic strategies for reducing CVD risk in T1D patients.
Main Methods:
- Literature review of studies investigating endothelial function in type 1 diabetes.
- Analysis of evidence for small molecule antioxidants (ascorbic acid, nicotinamide, taurine, folate, vitamin D).
Main Results:
- Ascorbic acid demonstrates efficacy in diminishing acute hyperglycemic effects and restoring endothelial function.
- Nicotinamide and taurine show promise as potential antioxidants based on in vitro and animal studies.
- Folate supplementation's benefit is uncertain, and vitamin D's role requires further investigation in T1D.
Conclusions:
- Antioxidant therapies, particularly ascorbic acid, show potential for improving endothelial function in type 1 diabetes.
- Further research into various small molecule antioxidants is warranted to reduce cardiovascular risk in this population.
Related Concept Videos
Type I Diabetes II: Pathophysiology
59
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
59
Type II Diabetes II: Pathophysiology
23
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
23
Diabetic Retinopathy
51
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
51
Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Type I Diabetes III: Clinical Manifestations
21
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
21
Type I Diabetes I: Introduction
41
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
41


